Abiopharma

🔍 TOWNSEND CHARLES C (Director)

Company: Gogo Inc. (GOGO)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 14,925 shares of Deferred Share Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 236,852.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each deferred share unit represents the contingent right to receive one share of the Company's common stock.
• F2: These deferred share units were granted on March 31, 2026, and immediately vest in full on the grant date. The deferred share units will be settled in shares of the Company's common stock following the director's termination of service on the Company's board of directors.